Netherlands· NL-bd30a57a29e8

ORALAIR 300 IR tabletten voor sublinguaal gebruik

A gräserpollen product containing allergenen van graspollenmengselextract (stallergenes s.a.), registered in Netherlands by Stallergenes. The same ATC class is registered in 11 of our 19 countries.

ATC V01AA02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about allergenen van graspollenmengselextract (stallergenes s.a.)Answers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Gräserpollen is registered in 11 of 19 countries.

Countries holding a registration under ATC V01AA02 (gräserpollen), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search gräserpollen products by name

Gräserpollen · ATC V01AA02

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ALLERGENEN VAN GRASPOLLENMENGSELEXTRACT (Stallergenes S.A.)
Manufacturer: Stallergenes
Country: Netherlands (NL)
ATC code: V01AA02
ATC class: Gräserpollen
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
105380

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under V01AA02

Gräserpollen, as other registers publish it.

All gräserpollen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/dba66285-507e-46e4-b08d-208602a97bd5
GET /v1/drugs/dba66285-507e-46e4-b08d-208602a97bd5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet voor sublinguaal gebruik",
  "route": "Sublinguaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h105380_smpc.pdf",
  "strength": null,
  "atc_label": "Grass Pollen",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg105380",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MANNITOL (D-) (E 421)",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "ALLERGENEN VAN GRASPOLLENMENGSELEXTRACT (Stallergenes S.A.)"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h105380.pdf",
  "authorised_at": "2010/01/25",
  "procedure_number": "DE/H/1930/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "105380",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about gräserpollen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console